Whitepaper & Video Center

LogiPharma AI & Tech Report 2026 [Register your interest]

LogiPharma AI & Tech Report 2026 [Register your interest]

The research explores three areas shaping the next phase of supply chain AI: the rise of agentic AI, building the intelligent supply chain, and turning AI investment into business impact. Across these themes, we examine where progress has been made, where friction remains and what leaders are prioritising over the next 24 months. Register your interest now!


The Agentic Supply Chain Operating Model [2026 Report]

The Agentic Supply Chain Operating Model [2026 Report]

This paper establishes the business case for the Agentic Supply Chain Operating Model and outlines the business and operational framework for the next major industrial revolution. Organizations that lead the next decade will be the first to leverage the financial advantages reaped from the transformation. Get your copy now!


The Agentic Supply Chain Operating System [2026 Report]

The Agentic Supply Chain Operating System [2026 Report]

Enterprise systems, cloud platforms, automation and AI have transformed supply chain operations. Is your supply chain technology built for the agentic era? This free report, The Agentic Supply Chain Operating System, explores what it takes to build the foundations for agentic operations. Get your copy now!


Rethinking Network Design in Pharmaceutical Supply Chains [2026 Report]

Rethinking Network Design in Pharmaceutical Supply Chains [2026 Report]

Pharmaceutical cold chain logistics has moved from specialist capability to strategic backbone. This study draws on the perspectives of 120 senior leaders across pharmaceutical manufacturers and freight forwarders, spanning North America, Europe and key growth markets in Asia. The majority of respondents represent pharmaceutical organisations and logistics partners, providing a cross-ecosystem view of cold chain performance.


INTERVIEW: Who is actually in control when disruption hits?

INTERVIEW: Who is actually in control when disruption hits?

In this video interview from SkyCell, Leigh Anne Mays speaks with HPCLC member David Komjati, a pharma and healthcare logistics leader with 25+ years of experience, about what Covid exposed in global pharma supply chains — and why disruption is no longer an exception.


Tool-Rich, Value-Constrained:  Why pharma supply chains are still struggling [2026 Report]

Tool-Rich, Value-Constrained: Why pharma supply chains are still struggling [2026 Report]

This research reveals a persistent gap between visibility and execution, with many organisations still relying on fragmented processes, manual intervention and lengthy approval cycles when disruption strikes. In our latest report, we explore why operational maturity has become the next critical challenge for the industry.


WEBINAR: From Validation Burden to Continuous Compliance

WEBINAR: From Validation Burden to Continuous Compliance

Manual validation processes are becoming one of the biggest barriers to agility in life sciences. In this practical LogiPharma webinar, experts from Staedean and Coripharma explore how organisations are moving towards continuous compliance through automated testing and modern validation approaches.


Our Sponsors: